Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.02 by 200 percent. This is a 66.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $48.56 million which beat the analyst consensus estimate of $48.32 million by 0.49 percent. This is a 17.36 percent increase over sales of $41.38 million the same period last year.